Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HFNC-SABA-ART study of salbutamol inhalation methods during high-flow nasal cannula in asthma and COPD
jRCTs041240198Recruiting
- Sponsor
- National Hospital Organization
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of salbutamol in asthma and chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by National Hospital Organization. Started Apr 2025; status: recruiting.
02
Drugs
salbutamol
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on jRCTs041240198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041240198.